Patterns of Intravenous Buprenorphine–Naloxone Misuse: Psychiatric Morbidity, Risk Behaviours, Diversion, and Serological Findings

Background: Intravenous misuse of buprenorphine–naloxone (BPNX) is a growing concern for patients with opioid use disorder (OUD). However, data on psychiatric comorbidities, patterns of diversion, and the burden of infectious diseases among individuals who inject BPNX in India remain limited. This study aimed to assess the clinical profile, diversion patterns, and seroprevalence among these patients. Methods: Seventy-three patients with a diagnosis of OUD injecting BPNX, were recruited for this study. Sociodemographic and clinical variables, diversion patterns, high-risk behaviors, and overdose history were assessed using a semi-structured proforma. Triple serology testing for HIV, HBV, and HCV was conducted, and relevant statistical analyses were performed. Results: The participants were predominantly young men with a mean age of 25.9 ± 6.05 years. Psychiatric comorbidity was present in 67.1% of participants, and attention-deficit hyperactivity disorder (ADHD) was the most common diagnosis. HCV seropositivity was found in 68.5% and HCV RNA in 52.05%. Most participants used both prescription and diverted BPNX to avoid withdrawal symptoms. High-frequency misuse was significantly linked to longer opioid dependence and needle sharing. Conclusions: The misuse of intravenous BPNX was linked to significant psychiatric comorbidity, unsafe injection practices, and a high burden of infectious diseases. The persistence of diversion despite the BPNX combination formulation suggests the current naloxone dose ratio may not be effective as a deterrent. Urgent integrated addiction, psychiatric, and harm-reduction services are needed.

Authors

Institutions

Publication Details

Journal
Indian Journal of Psychological Medicine
Published
2026-11-13
DOI
https://doi.org/10.1177/02537176261503189
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Patterns of Intravenous Buprenorphine–Naloxone Misuse: Psychiatric Morbidity, Risk Behaviours, Diversion, and Serological Findings

Inaamul Haq, Rajnish Raj, Fazle Roub Bhat, Zaid Ahmad Wani et al.
Indian Journal of Psychological Medicine
Opioid Use Disorder Treatment
article

Patterns of Intravenous Buprenorphine–Naloxone Misuse: Psychiatric Morbidity, Risk Behaviours, Diversion, and Serological Findings

Inaamul Haq, Rajnish Raj, Fazle Roub Bhat, Zaid Ahmad Wani, Aaliya Khanam, Yasir Hassan Rather, Sunny Gidwani, Mehroosh, Vaibhav Kumar Khare
article en

Abstract

Background: Intravenous misuse of buprenorphine–naloxone (BPNX) is a growing concern for patients with opioid use disorder (OUD). However, data on psychiatric comorbidities, patterns of diversion, and the burden of infectious diseases among individuals who inject BPNX in India remain limited. This study aimed to assess the clinical profile, diversion patterns, and seroprevalence among these patients. Methods: Seventy-three patients with a diagnosis of OUD injecting BPNX, were recruited for this study. Sociodemographic and clinical variables, diversion patterns, high-risk behaviors, and overdose history were assessed using a semi-structured proforma. Triple serology testing for HIV, HBV, and HCV was conducted, and relevant statistical analyses were performed. Results: The participants were predominantly young men with a mean age of 25.9 ± 6.05 years. Psychiatric comorbidity was present in 67.1% of participants, and attention-deficit hyperactivity disorder (ADHD) was the most common diagnosis. HCV seropositivity was found in 68.5% and HCV RNA in 52.05%. Most participants used both prescription and diverted BPNX to avoid withdrawal symptoms. High-frequency misuse was significantly linked to longer opioid dependence and needle sharing. Conclusions: The misuse of intravenous BPNX was linked to significant psychiatric comorbidity, unsafe injection practices, and a high burden of infectious diseases. The persistence of diversion despite the BPNX combination formulation suggests the current naloxone dose ratio may not be effective as a deterrent. Urgent integrated addiction, psychiatric, and harm-reduction services are needed.

Indian Journal of Psychological Medicine
Government Medical College (IN), Nalanda Medical College and Hospital (IN)
Good health and well-being
Opioid Use Disorder Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon